Top

Implementation Science

Published in:

Open Access 01-12-2019 | Systematic review

Factors influencing national implementation of innovations within community pharmacy: a systematic review applying the Consolidated Framework for Implementation Research

Authors: Natalie M. Weir, Rosemary Newham, Emma Dunlop, Marion Bennie

Published in: Implementation Science | Issue 1/2019

Abstract

Background

To meet emergent healthcare needs, innovations need to be implemented into routine clinical practice. Community pharmacy is increasingly considered a setting through which innovations can be implemented to achieve positive service and clinical outcomes. Small-scale pilot programmes often need scaled up nation-wide to affect population level change. This systematic review aims to identify facilitators and barriers to the national implementation of community pharmacy innovations.

Methods

A systematic review exploring pharmacy staff perspectives of the barriers and facilitators to implementing innovations at a national level was conducted. The databases Medline, EMBASE, PsycINFO, CINAHL, and Open Grey were searched and supplemented with additional search mechanisms such as Zetoc alerts. Eligible studies underwent quality assessment, and a directed content analysis approach to data extraction was conducted and aligned to the Consolidated Framework for Implementation Research (CFIR) to facilitate narrative synthesis.

Results

Thirty-nine studies were included: 16 were qualitative, 21 applied a questionnaire design, and 2 were mixed methods. Overarching thematic areas spanning across the CFIR domains were pharmacy staff engagement (e.g. their positive and negative perceptions), operationalisation of innovations (e.g. insufficient resources and training), and external engagement (e.g. the perceptions of patients and other healthcare professionals, and their relationship with the community pharmacy). Study participants commonly suggested improvements in the training offered, in the engagement strategies adopted, and in the design and quality of innovations.

Conclusions

This study’s focus on national innovations resulted in high-level recommendations to facilitate the development of successful national implementation strategies. These include (1) more robust piloting of innovations, (2) improved engagement strategies to increase awareness and acceptance of innovations, (3) promoting whole-team involvement within pharmacies to overcome time constraints, and (4) sufficient pre-implementation evaluation to gauge acceptance and appropriateness of innovations within real-world settings. The findings highlight the international challenge of balancing the professional, clinical, and commercial obligations within community pharmacy practice. A preliminary theory of how salient factors influence national implementation in the community pharmacy setting has been developed, with further research necessary to understand how the influence of these factors may differ within varying contexts.

Trial registration

A protocol for this systematic review was developed and uploaded onto the PROSPERO international prospective register of systematic reviews database (Registration number: CRD42016038876).

Available only for authorised users

Macinko J, Starfield B, Shi L. The contribution of primary care systems to health outcomes within Organization for Economic Cooperation and Development (OECD) countries, 1970–1998. Health Serv Res. 2003;38:831–65.PubMedPubMedCentral

World Health Organization. The world health report 2008: primary health care now more than ever. Geneva 2008 [cited 2018 Jun 12]. Available from: http://apps.who.int/medicinedocs/en/m/abstract/Js22232en/.

Wiedenmayer K, Summers R, Mackie C, Gous AGS, Everard M. Developing pharmacy practice: a focus on patient care: Geneval World Health Organization and International Pharmaceutical Federation; 2006.

Francis M, Hinchliffe A. Vaccination services through community pharmacy: a literature review: public health Wales; 2010 [cited 2018 Jun 12]. Available from: http://www.wales.nhs.uk/sitesplus/888/news/17071.

Brown TJ, Todd A, Malley C, Moore HJ, Husband AK, Bambra C, et al. Community pharmacy-delivered interventions for public health priorities: a systematic review of interventions for alcohol reduction, smoking cessation and weight management, including meta-analysis for smoking cessation. BMJ Open. 2016;6. https://doi.org/10.1136/bmjopen-2015-009828.

Lee E, Braund R, Tordoff J. Examining the first year of medicines use review services provided by pharmacists in New Zealand: 2008. N Z Med J. 2009;122:3566.PubMed

Hatah E, Braund R, Tordoff J, Duffull SB. A systematic review and meta-analysis of pharmacist-led fee-for-services medication review. Br J Clin Pharmacol. 2014;77:102–15. https://doi.org/10.1111/bcp.12140.PubMed

Frost TP, Adams AJ. Tech-check-tech in community pharmacy practice settings. J Pharm Technol. 2016;33:47–52. https://doi.org/10.1177/8755122516683519.PubMedCentral

Spinks J, Jackson J, Kirkpatrick CM, Wheeler AJ. Disruptive innovation in community pharmacy–impact of automation on the pharmacist workforce. Res Social Adm Pharm. 2017;13:394–7. https://doi.org/10.1016/j.sapharm.2016.04.009.PubMed

10.

World Health Organization. The role of the pharmacist in the health care system. New Delhi 1994 [cited 2018 Jun 12]. Available from: http://apps.who.int/medicinedocs/en/d/Jh2995e/.

11.

Todd A, Copeland A, Husband A, Kasim A, Bambra C. Access all areas? An area-level analysis of accessibility to general practice and community pharmacy services in England by urbanity and social deprivation. BMJ Open. 2015;5:e007328. https://doi.org/10.1136/bmjopen-2014-007328.PubMedPubMedCentral

12.

Todd A, Copeland A, Husband A, Kasim A, Bambra C. The positive pharmacy care law: an area-level analysis of the relationship between community pharmacy distribution, urbanity and social deprivation in England. BMJ Open. 2014;4:e005764. https://doi.org/10.1136/bmjopen-2014-005764.PubMedPubMedCentral

13.

Proctor E, Silmere H, Raghavan R, Hovmand P, Aarons G, Bunger A, et al. Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda. Admin Pol Ment Health. 2011;38:65–76. https://doi.org/10.1007/s10488-010-0319-7.

14.

Ben Charif A, Zomahoun HTV, LeBlanc A, Langlois L, Wolfenden L, Yoong SL, et al. Effective strategies for scaling up evidence-based practices in primary care: a systematic review. Implement Sci. 2017;12:139. https://doi.org/10.1186/s13012-017-0672-y.PubMedPubMedCentral

15.

Raine R, Fitzpatrick R, Barratt H, Bevan G, Black N, Boaden R, et al. Challenges, solutions and future directions in the evaluation of service innovations in health care and public health. Health services and delivery research. Southampton: NIHR Journals Library; 2016.

16.

Bush J, Langley CA, Wilson KA. The corporatization of community pharmacy: implications for service provision, the public health function, and pharmacy's claims to professional status in the United Kingdom. Res Social Adm Pharm. 2009;5:305–18. https://doi.org/10.1016/j.sapharm.2009.01.003.PubMed

17.

Barker PM, Reid A, Schall MW. A framework for scaling up health interventions: lessons from large-scale improvement initiatives in Africa. Implement Sci. 2016;11:1–11. https://doi.org/10.1186/s13012-016-0374-x.

18.

Rogers EM. Diffusion of innovations. 5th ed. New York: Free Press; 2003.

19.

Tann J, Blenkinsopp A, Allen J, Platts A. Leading edge practitioners in community pharmacy: approaches to innovation. Int J Pharm Pract. 1996;4:235–45. https://doi.org/10.1111/j.2042-7174.1996.tb00874.x.

20.

Roberts AS, Benrimoj SI, Chen TF, Williams KA, Aslani P. Implementing cognitive services in community pharmacy: a review of facilitators used in practice change. Int J Pharm Pract. 2006;14:163–70. https://doi.org/10.1211/ijpp.14.3.0002.

21.

Shoemaker SJ, Curran GM, Swan H, Teeter BS, Thomas J. Application of the consolidated framework for implementation research to community pharmacy: a framework for implementation research on pharmacy services. Res Social Adm Pharm. 2017;13:905–13. https://doi.org/10.1016/j.sapharm.2017.06.001.PubMed

22.

Moher D, Liberati A, Tetzlaff J, Altman DG, The PG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097. https://doi.org/10.1371/journal.pmed.1000097.PubMedPubMedCentral

23.

Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Systematic Reviews. 2015;4:1. https://doi.org/10.1186/2046-4053-4-1.PubMedPubMedCentral

24.

Noyes J, Booth A, Hannes K, Harden A, Harris J, Lewin S, et al. Supplementary guidance for inclusion of qualitative research in cochrane systematic reviews of interventions. Cochrane Collaboration Qualitative Methods Group, 2011. Version 1 (updated August 2011). [cited 2016 Feb 2]. Available from: http://cqrmg.cochrane.org/supplemental-handbook-guidance.

25.

PROSPERO: International prospective register of systematic reviews. : National Institute for Health Research; 2016 [cited 2018 Jun 11]. Available from: https://www.crd.york.ac.uk/PROSPERO/.

26.

Greenhalgh T, Robert G, Bate P, Macfarlane F, Kyriakidou O, Donaldson L. Diffusion of innovations in health service organisations: a systematic literature review. London: Wiley; 2007.

27.

Rabin BA, Purcell P, Naveed S, Moser RP, Henton MD, Proctor EK, et al. Advancing the application, quality and harmonization of implementation science measures. Implement Sci. 2012;7. https://doi.org/10.1186/1748-5908-7-119.

28.

Open Grey. System for Information on Grey Literature [cited 2018 Feb]. Available from: http://www.opengrey.eu.

29.

Covidence. Better systematic review management [cited 2018 Oct] Available from: https://www.covidence.org/home.

30.

Cicchetti DV. The precision of reliability and validity estimates re-visited: distinguishing between clinical and statistical significance of sample size requirements. J Clin Exp Neuropsychol. 2001;23:695–700. https://doi.org/10.1076/jcen.23.5.695.1249.PubMed

31.

House AE, House BJ, Campbell MB. Measures of interobserver agreement: calculation formulas and distribution effects. J Behav Assess. 1981;3:37–57. https://doi.org/10.1007/BF01321350.

32.

Critical Appraisal Skills Programme. CASP Qualitative Checklist 2018 [cited 2018 Feb]. Available from: http://www.casp-uk.net/.

33.

Heyvaert M, Hannes K, Maes B, Onghena P. Critical appraisal of mixed methods studies. J Mix Methods Res. 2013;7:302–27. https://doi.org/10.1177/1558689813479449.

34.

Pluye P, Robert E, Cargo M, Bartlett G, O’Cathain A, Griffiths F, et al. Proposal: a mixed methods appraisal tool for systematic mixed studies reviews. 2011 [cited 2018 12th of June]. Available from: http://mixedmethodsappraisaltoolpublic.pbworks.com.

35.

Mills EJ, Nachega JB, Bangsberg DR, Singh S, Rachlis B, Wu P, et al. Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Med. 2006;3:e438. https://doi.org/10.1371/journal.pmed.0030438.PubMedPubMedCentral

36.

Masood M, Thaliath ET, Bower EJ, Newton JT. An appraisal of the quality of published qualitative dental research. Community Dent Oral Epidemiol. 2011;39:193–203. https://doi.org/10.1111/j.1600-0528.2010.00584.x.PubMed

37.

Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009;4:1–15. https://doi.org/10.1186/1748-5908-4-50.

38.

Nilsen P. Making sense of implementation theories, models and frameworks. Implement Sci. 2015;10:53. https://doi.org/10.1186/s13012-015-0242-0.PubMedPubMedCentral

39.

Birken SA, Powell BJ, Shea CM, Haines ER, Alexis Kirk M, Leeman J, et al. Criteria for selecting implementation science theories and frameworks: results from an international survey. Implement Sci. 2017;12:124. https://doi.org/10.1186/s13012-017-0656-y.PubMedPubMedCentral

40.

Kirk MA, Kelley C, Yankey N, Birken SA, Abadie B, Damschroder L. A systematic review of the use of the Consolidated Framework for Implementation Research. Implement Sci. 2015;11:72. https://doi.org/10.1186/s13012-016-0437-z.

41.

Kirk MA, Kelley C, Yankey N, Birken SA, Abadie B, Damschroder L. A systematic review of the use of the consolidated framework for implementation research. Implement Sci. 2016;11:72. https://doi.org/10.1186/s13012-016-0437-z.PubMedPubMedCentral

42.

Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15:1277–88. https://doi.org/10.1177/1049732305276687.PubMed

43.

Elo S, Kyngas H. The qualitative content analysis process. J Adv Nurs. 2008;62:107–15. https://doi.org/10.1111/j.1365-2648.2007.04569.x.PubMed

44.

Green SA, Bell D, Mays N. Identification of factors that support successful implementation of care bundles in the acute medical setting: a qualitative study. BMC Health Serv Res. 2017;17:120. https://doi.org/10.1186/s12913-017-2070-1.PubMedPubMedCentral

45.

Keith RE, Crosson JC, O'Malley AS, Cromp D, Taylor EF. Using the Consolidated Framework for Implementation Research (CFIR) to produce actionable findings: a rapid-cycle evaluation approach to improving implementation. Implement Sci. 2017;12:15. https://doi.org/10.1186/s13012-017-0550-7.PubMedPubMedCentral

46.

Noyes J, Lewin S. Chapter 6: supplemental guidance on selecting a method of qualitative evidence synthesis, and integrating qualitative evidence with cochrane intervention reviews. In: Noyes J, Booth A, Hannes K, Harden A, Harris J, Lewin S, et al., editors. Supplementary guidance for inclusion of qualitative research in cochrane systematic reviews of interventions version 1 (updated August 2011) Cochrane Collaboration Qualitative Methods Group; 2011.

47.

Popay J, Roberts H, Sowden A, Petticrew M, Arai L, Rodgers M, et al. Guidance on the conduct of narrative synthesis in systematic reviews. A product from the ESRC methods programme; 2006 [cited 2018 Oct] Available from: https://www.lancaster.ac.uk/shm/research/nssr/research/dissemination/publications.php.

48.

Dixon-Woods M, Agarwal S, Jones D, Young B, Sutton A. Synthesising qualitative and quantitative evidence: a review of possible methods. J Health Serv Res Policy. 2005;10:45–53. https://doi.org/10.1177/135581960501000110.PubMed

49.

Carroll C, Booth A, Lloyd-Jones M. Should we exclude inadequately reported studies from qualitative systematic reviews? An evaluation of sensitivity analyses in two case study reviews. Qual Health Res. 2012;22:1425–34. https://doi.org/10.1177/1049732312452937.PubMed

50.

Allenet B, Barry H. Opinion and behaviour of pharmacists towards the substitution of branded drugs by generic drugs: survey of 1,000 French community pharmacists. Pharm World Sci. 2003;25:197–202.PubMed

51.

Bawazir S. Attitude of community pharmacists in saudi arabia towards adverse drug reaction reporting. Saudi Pharm J. 2006;14:75–83. https://doi.org/10.1016/j.jsps.2018.11.002.

52.

Bell CA, Eang MT, Dareth M, Rothmony E, Duncan GJ, Saini B. Provider perceptions of pharmacy-initiated tuberculosis referral services in Cambodia, 2005-2010. Int J Tuberc Lung Dis. 2012;16:1086–91.PubMed

53.

Blenkinsopp A, Celino G, Bond C, Inch J, Gray N. Community pharmacists’ experience of providing medicines use reviews: findings from the national evaluation of the community pharmacy contractual framework. Int J Pharm Pract. 2007;15:B45–B6. https://doi.org/10.1211/096176707781890707.

54.

Brooks D, Hopp A, White S. Perspectives of community pharmacy staff on healthy living pharmacies: a qualitative study. Int J Clin Pharm. 2013;21:16.

55.

Chaar BB, Wang H, Day CA, Hanrahan JR, Winstock AR, Fois R. Factors influencing pharmacy services in opioid substitution treatment. Drug Alcohol Rev. 2013;32:426–34. https://doi.org/10.1111/dar.12032.

56.

Corlett S, Dodds L. The new medicines service; initial views and early experiences of community pharmacists in Kent. Int J Clin Pharm. 2013;21:96–7.

57.

Donovan GR, Paudyal V. England’s Healthy Living Pharmacy (HLP) initiative: facilitating the engagement of pharmacy support staff in public health. Res Social Adm Pharm. 2016;12:281–92. https://doi.org/10.1016/j.sapharm.2015.05.010.PubMed

58.

Duarte M, Ferreira P, Soares M, Cavaco A, Martins AP. Community pharmacists’ attitudes towards adverse drug reaction reporting and their knowledge of the new pharmacovigilance legislation in the southern region of Portugal: a mixed methods study. Drugs Ther Perspect. 2015;31:316–22. https://doi.org/10.1007/s40267-015-0227-8.

59.

Elkalmi RM, Hassali MA, Ibrahim MI, Jamshed SQ, Al-Lela OQ. Community pharmacists' attitudes, perceptions, and barriers toward adverse drug reaction reporting in Malaysia: a quantitative insight. J Patient Saf. 2014;10:81–7. https://doi.org/10.1097/pts.0000000000000051.PubMed

60.

Elkalmi RM, Hassali MA, Ibrahim MIM, Liau SY, Awaisu A. A qualitative study exploring barriers and facilitators for reporting of adverse drug reactions (ADRs) among community pharmacists in Malaysia. J Pharm Health Serv Res. 2011;2:71–8. https://doi.org/10.1111/j.1759-8893.2011.00037.x.

61.

Firth H, Todd A, Bambra C. Benefits and barriers to the public health pharmacy: a qualitative exploration of providers’ and commissioners’ perceptions of the Healthy Living Pharmacy Framework. Perspect Public Health. 2015;135:251–6.PubMed

62.

Gauld N, Kelly F, Shaw J. Is non-prescription oseltamivir availability under strict criteria workable? A qualitative study in New Zealand. J Antimicrob Chemother. 2011;66:201–4. https://doi.org/10.1093/jac/dkq409.PubMed

63.

Gröber-Grätz D, Gulich M. Impact of drug discount contracts on pharmacies and on patients’ drug supply. J Public Health. 2010;18:583–9. https://doi.org/10.1007/s10389-010-0338-6.

64.

Hammar T, Nystrom S, Petersson G, Rydberg T, Astrand B. Swedish pharmacists value eprescribing: a survey of a nationwide implementation. J Pharm Health Serv Res. 2010;1:23–32. https://doi.org/10.1211/jphsr.01.01.0012.

65.

Hamrosi KK, Raynor DK, Aslani P. Enhancing provision of written medicine information in Australia: pharmacist, general practitioner and consumer perceptions of the barriers and facilitators. BMC Health Serv Res. 2014;14:183. https://doi.org/10.1186/1472-6963-14-183.PubMedPubMedCentral

66.

Hansford D, Cunningham S, John D, McCaig D, Stewart D. Community pharmacists’ views, attitudes and early experiences of over-the-counter simvastatin. Pharm World Sci. 2007;29:380–5. https://doi.org/10.1007/s11096-007-9084-4.PubMed

67.

Hodson K, James D, Smith M, Hughes L, Blenkinsopp A, Cohen D, et al. Evaluation of the discharge medicines review service in Wales: community and hospital pharmacists’ views. Int J Clin Pharm. 2014;22:6. doi: https://doi.org/10.1111/ijpp.12142.

68.

Irujo M, Beitia G, Bes-Rastrollo M, Figueiras A, Hernandez-Diaz S, Lasheras B. Factors that influence under-reporting of suspected adverse drug reactions among community pharmacists in a Spanish region. Drug Saf. 2007;30:1073–82. https://doi.org/10.2165/00002018-200730110-00006.

69.

Kaae S, Søndergaard B, Haugbølle LS, Traulsen JM. The relationship between leadership style and provision of the first Danish publicly reimbursed cognitive pharmaceutical service—a qualitative multicase study. Res Social Adm Pharm. 2011;7:113–21. https://doi.org/10.1016/j.sapharm.2010.03.001.PubMed

70.

Kaae S, Sondergaard B, Stig L, Traulsen JM. Sustaining delivery of the first publicly reimbursed cognitive service in Denmark: a cross-case analysis. Int J Pharm Pract. 2010;18:21–7.PubMed

71.

Kansanaho H, Puumalainen I, Varunki M, Ahonen R, Airaksinen M. Implementation of a professional program in Finnish community pharmacies in 2000-2002. Patient Educ Couns. 2005;57:272–9. https://doi.org/10.1016/j.pec.2004.07.014.

72.

Latif A, Boardman H. Community pharmacists’ attitudes towards medicines use reviews and factors affecting the numbers performed. Pharm World Sci. 2008;30:536–43.PubMed

73.

Latif A, Mahmood K, Boardman H. Medicines use reviews–how have pharmacists’ views changed? Int J Clin Pharm. 2010;18:69–70.

74.

Latif A, Waring J, Watmough D, Barber N, Chuter A, Davies J, et al. Examination of England's New Medicine Service (NMS) of complex health care interventions in community pharmacy. Res Social Adm Pharm. 2016;12:966–89. https://doi.org/10.1016/j.sapharm.2015.12.007.PubMed

75.

Lonergan C, O'Grady M, Byrne S. An exploratory study of codeine sales restrictions within Irish pharmacies, a qualitative study. Int J Pharm Pract. 2012;20:43.

76.

Loo RL, Diaper C, Salami OT, Kundu M, Lalkia M, Airhiavbere E, et al. The NHS Health Check: the views of community pharmacists. Int J Pharm Pract. 2011;19:13. https://doi.org/10.1111/j.2042-7174.2011.00142.x.

77.

Lucas B, Blenkinsopp A. Community pharmacists' experience and perceptions of the New Medicines Service (NMS). Int J Pharm Pract. 2015;23:399–406. https://doi.org/10.1111/ijpp.12180.PubMed

78.

Paudyal V, Hansford D, Cunningham S, Stewart D. Pharmacists’ perceived integration into practice of over-the-counter simvastatin five years post reclassification. Int J Clin Pharm. 2012;34:733–8. https://doi.org/10.1007/s11096-012-9668-5.PubMed

79.

Paudyal V, Hansford D, Scott Cunningham IT, Stewart D. Cross-sectional survey of community pharmacists’ views of the electronic Minor Ailment Service in Scotland. Int J Pharm Pract. 2010;18:194–201. https://doi.org/10.1111/j.2042-7174.2010.00042.x.PubMed

80.

Ping CC, March G, Clark A, Gilbert A, Hassali MA, Bahari MB. A web-based survey on Australian community pharmacists’ perceptions and practices of generic substitution. J Generic Med. 2010;7:342–53. https://doi.org/10.1057/jgm.2010.23.

81.

Rahimi B, Timpka T. Pharmacists’ views on integrated electronic prescribing systems: associations between usefulness, pharmacological safety, and barriers to technology use. Eur J Clin Pharmacol. 2011;67:179–84. https://doi.org/10.1007/s00228-010-0936-9.PubMed

82.

Rutter P, Vryaparj G. Qualitative exploration of the views of healthy living champions from pharmacies in England. Int J Clin Pharm. 2015;37:27–30. https://doi.org/10.1007/s11096-014-0055-2.PubMed

83.

Shevket O, White S. A qualitative follow-up study of the perspectives of community pharmacy staff on Healthy Living Pharmacies. Int J Clin Pharm. 2015;23:69–70.

84.

Thomas T, Hathiari A, Benson C, Oladosu B. Controlled drugs: are they being controlled? An evaluation of the views, understanding and implementation of the amended Controlled Drug Regulations (2006) by community pharmacists. Int J Pharm Pract. 2009;17:75. https://doi.org/10.1211/096176709789037155.

85.

Van Grootheest AC, den Berg LTWJ-v, Mes K. Attitudes of community pharmacists in the Netherlands towards adverse drug reaction reporting. Int J Pharm Pract. 2002;10:267–72. https://doi.org/10.1211/096176702776868460.

86.

Weidmann AE, Cunningham S, Gray G, Hansford D, McLay J, Broom J, et al. Over-the-counter orlistat: early experiences, views and attitudes of community pharmacists in Great Britain. Int J Clin Pharm. 2011;33:627–33. https://doi.org/10.1007/s11096-011-9516-z.PubMed

87.

Wilcock M, Harding G. What do pharmacists think of MURs and do they change prescribed medication? Pharm J. 2007;281:163.

88.

Bassi M, Wood K. Medicines use reviews: time for a new name? Int J Pharm Pract. 2009;17(S2):B4–5. https://doi.org/10.1211/096176709789037119.

89.

Gossell-Williams M, Adebayo SA. The pharmwatch programme: challenges to engaging the community pharmacists in Jamaica. Pharm Pract. 2008;6:187–90.

90.

Qassim S, Metwaly Z, Shamsain M, AlHariri Y. Spontaneous reporting of adverse drug reactions in uae: obstacles and motivation among community pharmacists. Int J Pharm Sci Res. 2014;5:4203–8.

91.

Toklu HZ, Uysal MK. The knowledge and attitude of the Turkish community pharmacists toward pharmacovigilance in the Kadikoy district of Istanbul. Pharm World Sci. 2008;30:556–27. https://doi.org/10.1007/s11096-008-9209-4.

92.

Hersberger KE, Renggli VP, Nirkko AC, Mathis J, Schwegler K, Bloch KE. Screening for sleep disorders in community pharmacies -- evaluation of a campaign in Switzerland. J Clin Pharm Ther. 2006;31:35–41. doi: https://doi.org/10.1111/j.1365-2710.2006.00698.x.

93.

CFIR Research Team. Consolidated Framework for Implementation Research: Tools and Templates 2018. Available from: https://cfirguide.org/tools/tools-and-templates/.

94.

Luetsch K. Attitudes and attributes of pharmacists in relation to practice change – a scoping review and discussion. Res Social Adm Pharm. 2017;13:440–55.e11. https://doi.org/10.1016/j.sapharm.2016.06.010.PubMed

95.

Wingfield J, Bissell P, Anderson C. The scope of pharmacy ethics-an evaluation of the international research literature, 1990-2002. Soc Sci Med. 2004;58:2383–96. https://doi.org/10.1016/j.socscimed.2003.09.003.PubMed

96.

Cooper RJ, Bissell P, Wingfield J. A new prescription for empirical ethics research in pharmacy: a critical review of the literature. J Med Ethics. 2007;33:82–6. https://doi.org/10.1136/jme.2005.015297.PubMedPubMedCentral

97.

Powers MF, Bright DR. Pharmacy technicians and medication therapy management. J Pharm Technol. 2008;24:336–9. https://doi.org/10.1177/875512250802400604.

98.

Powers MF, Hohmeier KC. Pharmacy technicians and immunizations. J Pharm Technol. 2011;27:111–6. https://doi.org/10.1177/875512251102700303.

99.

Roberts AS, Benrimoj SI, Chen TF, Williams KA, Hopp TR, Aslani P. Understanding practice change in community pharmacy: a qualitative study in Australia. Res Social Adm Pharm. 2005;1:546–64. https://doi.org/10.1016/j.sapharm.2005.09.003.PubMed

100.

John C, Brown A. Technicians and other pharmacy support workforce cadres working with pharmacists: United Kingdom case study. Res Social Adm Pharm. 2017;13:297–9. https://doi.org/10.1016/j.sapharm.2016.10.007.PubMed

101.

Koehler T, Brown A. Documenting the evolution of the relationship between the pharmacy support workforce and pharmacists to support patient care. Res Social Adm Pharm. 13:280–5. https://doi.org/10.1016/j.sapharm.2016.10.012.

102.

Kilbourne AM, Neumann MS, Pincus HA, Bauer MS, Stall R. Implementing evidence-based interventions in health care: application of the replicating effective programs framework. Implement Sci. 2007;2:42. https://doi.org/10.1186/1748-5908-2-42.PubMedPubMedCentral

103.

Balasubramanian BA, Cohen DJ, Davis MM, Gunn R, Dickinson LM, Miller WL, et al. Learning evaluation: blending quality improvement and implementation research methods to study healthcare innovations. Implement Sci. 2015;10:31. https://doi.org/10.1186/s13012-015-0219-z.PubMedPubMedCentral

104.

Blondal AB, Jonsson JS, Sporrong SK, Almarsdottir AB. General practitioners’ perceptions of the current status and pharmacists’ contribution to primary care in Iceland. Int J Clin Pharm. 2017;39:945–52. https://doi.org/10.1007/s11096-017-0478-7.PubMed

105.

Moore T, Kennedy J, McCarthy S. Exploring the general practitioner-pharmacist relationship in the community setting in Ireland. Int J Pharm Pract. 2014;22:327–34. https://doi.org/10.1111/ijpp.12084.PubMed

106.

Bryant LJM, Coster G, Gamble GD, McCormick RN. General practitioners’ and pharmacists’ perceptions of the role of community pharmacists in delivering clinical services. Res Social Adm Pharm. 2009;5:347–62. https://doi.org/10.1016/j.sapharm.2009.01.002.PubMed

107.

Bryant L, Maney J, Martini N. Changing perspectives of the role of community pharmacists: 1998–2012. J Prim Health Care. 2017;9:34–46. https://doi.org/10.1071/HC16032.PubMed

108.

Edmunds J, Calnan MW. The reprofessionalisation of community pharmacy? An exploration of attitudes to extended roles for community pharmacists amongst pharmacists and general practioners in the United Kingdom. Soc Sci Med. 2001;53:943–55. https://doi.org/10.1016/S0277-9536(00)00393-2.PubMed

109.

Hughes CM, McCann S. Perceived interprofessional barriers between community pharmacists and general practitioners: a qualitative assessment. Br J Gen Pract. 2003;53:600–6.PubMedPubMedCentral

110.

Naik Panvelkar P, Saini B, Armour C. Measurement of patient satisfaction with community pharmacy services: a review. Pharm World Sci. 2009;31:525–37. https://doi.org/10.1007/s11096-009-9311-2.PubMed

111.

Gammie SM, Rodgers RM, Loo RL, Corlett SA, Krska J. Medicine-related services in community pharmacy: public preferences for pharmacy attributes and promotional methods and comparison with pharmacists’ perceptions. Pateint Prefer Adherance. 2016;10:2297–307. https://doi.org/10.2147/PPA.S112932.

112.

Gidman W, Ward P, McGregor L. Understanding public trust in services provided by community pharmacists relative to those provided by general practitioners: a qualitative study. BMJ Open. 2012;2. https://doi.org/10.1136/bmjopen-2012-000939.

113.

Krska J, Morecroft CW. Views of the general public on the role of pharmacy in public health. J Pharm Health Serv Res. 2010;1:33–8. https://doi.org/10.1211/jphsr.01.01.0013.

114.

Cavaco AM, Dias JP, Bates IP. Consumers’ perceptions of community pharmacy in Portugal: a qualitative exploratory study. Pharm World Sci. 2005;27:54–60.PubMed

115.

Al-Arifi MN. Patients’ perception, views and satisfaction with pharmacists' role as health care provider in community pharmacy setting at Riyadh, Saudi Arabia. Saudi Pharm J. 2012;20:323–30. https://doi.org/10.1016/j.jsps.2012.05.007.PubMedPubMedCentral

116.

Pinnock H, Barwick M, Carpenter CR, Eldridge S, Grandes G, Griffiths CJ, et al. Standards for Reporting Implementation Studies (StaRI): explanation and elaboration document. BMJ Open. 2017;7. https://doi.org/10.1136/bmj.i6795.

117.

Proctor EK, Powell BJ, McMillen JC. Implementation strategies: recommendations for specifying and reporting. Implement Sci. 2013;8:139. https://doi.org/10.1186/1748-5908-8-139.PubMedPubMedCentral

118.

Gagnon MP, Nsangou ER, Payne-Gagnon J, Grenier S, Sicotte C. Barriers and facilitators to implementing electronic prescription: a systematic review of user groups' perceptions. J Am Med Inform Assoc. 2014;21:535–41. https://doi.org/10.1136/amiajnl-2013-002203.PubMed

119.

Gravel K, Legare F, Graham ID. Barriers and facilitators to implementing shared decision-making in clinical practice: a systematic review of health professionals' perceptions. Implement Sci. 2006;1:16. https://doi.org/10.1186/1748-5908-1-16.PubMedPubMedCentral

120.

Geerligs L, Rankin NM, Shepherd HL, Butow P. Hospital-based interventions: a systematic review of staff-reported barriers and facilitators to implementation processes. Implement Sci. 2018;13:36. https://doi.org/10.1186/s13012-018-0726-9.PubMedPubMedCentral

121.

Chaudoir SR, Dugan AG, Barr CH. Measuring factors affecting implementation of health innovations: a systematic review of structural, organizational, provider, patient, and innovation level measures. Implement Sci. 2013;8:22. https://doi.org/10.1186/1748-5908-8-22.PubMedPubMedCentral

Title: Factors influencing national implementation of innovations within community pharmacy: a systematic review applying the Consolidated Framework for Implementation Research
Authors: Natalie M. Weir
Rosemary Newham
Emma Dunlop
Marion Bennie
Publication date: 01-12-2019
Publisher: BioMed Central
Published in: Implementation Science / Issue 1/2019
Electronic ISSN: 1748-5908
DOI: https://doi.org/10.1186/s13012-019-0867-5

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Factors influencing national implementation of innovations within community pharmacy: a systematic review applying the Consolidated Framework for Implementation Research

Abstract

Background

Methods

Results

Conclusions

Trial registration

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Trial registration

Please log in to get access to this content

Other articles of this Issue 1/2019

Study protocol: a pragmatic, stepped-wedge trial of tailored support for implementing social determinants of health documentation/action in community health centers, with realist evaluation

Testing an implementation strategy bundle on adoption and sustainability of evidence to optimize physical function in community-dwelling disabled and older adults in a Medicaid waiver: a multi-site pragmatic hybrid type III protocol

Variation in the operationalisation of dose in implementation of health promotion interventions: insights and recommendations from a scoping review

Barriers and facilitators to the successful development, implementation and evaluation of care bundles in acute care in hospital: a scoping review

A stepped-wedge cluster randomized trial designed to improve completion of HPV vaccine series and reduce missed opportunities to vaccinate in rural primary care practices

Scaling-up the Systems Analysis and Improvement Approach for prevention of mother-to-child HIV transmission in Mozambique (SAIA-SCALE): a stepped-wedge cluster randomized trial